Literature DB >> 7538682

Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses.

A F Watkinson1, J Ellul, K Entwisle, R C Mason, A Adam.   

Abstract

PURPOSE: To assess the effectiveness of a polyurethane-covered self-expanding metallic endoprosthesis in the relief of dysphagia due to irresectable esophageal carcinoma.
MATERIALS AND METHODS: Thirty-two patients (20 men, 12 women) aged 41-89 years (median, 70 years) with inoperable esophageal carcinoma underwent stent placement (44 stents). All patients underwent both clinical and radiologic examination before and after treatment. Clinical follow-up was performed at 4-week intervals.
RESULTS: Stent placement was successful in all patients, with good symptomatic relief and no serious complications. Eleven patients needed more than one stent because of early partial migration, late complete migration, tumor overgrowth, or long stricture. Seven patients had associated esophageal fistulization or perforation; leaks were successfully sealed after stent insertion. The mean dysphagia score was 3.38 +/- 0.49 (standard deviation) before treatment and 0.81 +/- 0.88 at 3-4 days after insertion. Nineteen patients died, with a median survival time of 78 days (range, 12-245 days), and 13 were alive 14-67 days (median, 30 days) after treatment and were swallowing a near normal diet.
CONCLUSION: The insertion of plastic-covered endoprostheses provides rapid, safe, and effective palliation of malignant esophageal obstruction.

Entities:  

Mesh:

Year:  1995        PMID: 7538682     DOI: 10.1148/radiology.195.3.7538682

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method.

Authors:  R Singhvi; F Abbasakoor; J M Manson
Journal:  Ann R Coll Surg Engl       Date:  2000-07       Impact factor: 1.891

2.  Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.

Authors:  Terufumi Kawamoto; Keiji Nihei; Keisuke Sasai; Katsuyuki Karasawa
Journal:  Int J Clin Oncol       Date:  2018-07-31       Impact factor: 3.402

3.  Is there a beneficial role for a flexible bronchoscopic approach to oesophageal tumour-related tracheobronchial stenosis?

Authors:  Emmet E McGrath; David Warriner; Paul Anderson
Journal:  Lung       Date:  2011-06-19       Impact factor: 2.584

4.  Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial.

Authors:  Amit Javed; Sujoy Pal; Nihar Ranjan Dash; Vineet Ahuja; Bidhu Kalyan Mohanti; Sreenivas Vishnubhatla; Peush Sahni; Tushar Kanti Chattopadhyay
Journal:  J Gastrointest Cancer       Date:  2012-03

Review 5.  Interventional oncology in multidisciplinary cancer treatment in the 21(st) century.

Authors:  Andreas Adam; Lizbeth M Kenny
Journal:  Nat Rev Clin Oncol       Date:  2014-12-02       Impact factor: 66.675

6.  Esophageal stenting.

Authors:  Andrew S Lowe; Maria B Sheridan
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

7.  Metallic endoprostheses for malignant tracheobronchial obstruction: initial experience.

Authors:  B S Tan; A F Watkinson; J E Dussek; A N Adam
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Mar-Apr       Impact factor: 2.740

8.  A rare life-threatening complication of migrated nitinol self-expanding metallic stent (Ultraflex).

Authors:  H S S Ho; H S Ong
Journal:  Surg Endosc       Date:  2004-02       Impact factor: 4.584

9.  Self-expanding metal stents in palliation of malignant dysphagia: outcome of 124 Egyptian patients.

Authors:  Asser Abdel Raouf Elsharkawy; A A El-Geidie
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-13       Impact factor: 2.503

10.  A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.

Authors:  T Sabharwal; M S Hamady; S Chui; S Atkinson; R Mason; A Adam
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.